EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Acne characteristics in Latin American patients and the potential role of trifarotene

Marco A D da Rocha iD, Leonel Fierro-Arias iD, Emilia N Cohen Sabban, Ricardo S Castillo, Rajeev Chavda, Luiz M Almeida

International Journal of Dermatology · 2023

DOI: 10.1111/ijd.16754 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Dermatology, 2023. Verfasst von Marco A D da Rocha und 5 weiteren Autor:innen. Beteiligte Einrichtung: Federal University of São Paulo, São Paulo, Brazil. Hauptthemen laut MEDLINE: Acne Vulgaris, Dermatologic Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Galderma International.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Individualization of treatment based on acne type and severity, location, disease burden, and patient preference is required to maximize efficacy, safety, and adherence to therapy. Latin American populations have unique attributes that must be considered as part of this process to improve clinical success and achieve patient goals. Acne is more common among patients with darker skin phototypes, in whom it is often associated with postinflammatory hyperpigmentation and scarring—the most important acne sequelae—potentially due to more frequent and more severe underlying inflammatory processes in this population.

Discussion

These data argue for an early and proactive approach to managing acne in these patients with agents that target the inflammatory processes that underlie acne and its sequelae. As a class, retinoids offer a spectrum of activity that may be useful in addressing the unique needs of Latin American populations.

Conclusion

Trifarotene, a novel, selective retinoid, has been evaluated in relevant patient populations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acne VulgarisDermatologic AgentsHumansLatin AmericaRetinoidsCicatrixTreatment Outcome

Substanzen

trifaroteneRetinoidsDermatologic Agents

Autor:innen und Institutionen

  • Federal University of São Paulo, São Paulo, Brazil.
  • ABC Medical Center, Hospital General de México, Mexico City, Mexico.
  • Instituto de Investigaciones Médicas A. Lanari, University of Buenos Aires, Buenos Aires, Argentina.
  • Celaskin Dermatology Clinic, Región Metropolitana, Chile.
  • Galderma Research & Development, Lausanne, Switzerland.
  • Santa Casa de Belo Horizonte, Belo Horizonte, MG, Brazil.

ORCID-Profile: Marco A D da Rocha, Leonel Fierro-Arias

Förderung

  • Galderma International

Zitieren

APA

da Rocha, M. A. D., Fierro-Arias, L., Cohen Sabban, E. N., Castillo, R. S., Chavda, R., & Almeida, L. M. (2023). Acne characteristics in Latin American patients and the potential role of trifarotene. International Journal of Dermatology. https://doi.org/10.1111/ijd.16754

Vancouver

da Rocha MAD, Fierro-Arias L, Cohen Sabban EN, Castillo RS, Chavda R, Almeida LM. Acne characteristics in Latin American patients and the potential role of trifarotene. International Journal of Dermatology. 2023. doi:10.1111/ijd.16754

BibTeX
@article{daRocha2023,
  author = {da Rocha, Marco A D and Fierro-Arias, Leonel and Cohen Sabban, Emilia N and Castillo, Ricardo S and Chavda, Rajeev and Almeida, Luiz M},
  title = {Acne characteristics in Latin American patients and the potential role of trifarotene},
  journal = {International Journal of Dermatology},
  year = {2023},
  doi = {10.1111/ijd.16754}
}
Kostenlos starten →